Results 131 to 140 of about 2,404 (154)

Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland. [PDF]

Appl Health Econ Health Policy
Bainbridge J, Mealing S, Graham C, Jenal M, von Dombrowski N, Dymond A.   +5 more
europepmc   +1 more source

Pediatricians' attitudes and knowledge of RSV immunization products: A multi-country cross-sectional survey. [PDF]

PLoS One
Di Chiara C, Piché-Renaud PP, Rigamonti V, Cantarutti A, Calvo C, Rivero Calle I, Soriano-Arandes A, Giaquinto C, Cantarutti L, Donà D, Lo Vecchio A, Hadjipanayis A, Pana ZD, Kopsidas I, Rose A, Tagarro A, Morris SK.   +16 more
europepmc   +1 more source

Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network. [PDF]

Lancet Reg Health West Pac
Wadia U, Richmond PC, Britton PN, Carr J, Clark JE, Crawford NW, Hung TY, Marshall HS, Macartney KK, Wood NJ, McMullan BJ, Moore HC, Effler PV, Cheng AC, Blyth CC, PAEDS-FluCAN Network.   +15 more
europepmc   +1 more source

Maternal Immunization Against Respiratory Syncytial Virus: An Updated WAidid Consensus Document on Evidence, Implementation, and Public Health Priorities. [PDF]

Vaccines (Basel)
Esposito S, Riccò M, Abu-Raya B, Icardi G, Spoulou V, Greenberg D, Falup Pecurariu O, Hung IF, Osterhaus A, Sambri V, Principi N.   +10 more
europepmc   +1 more source

Analysis of the Economic and Public Health Impact of New Immunization Strategies in Infants Against Respiratory Syncytial Virus (RSV) in Colombia. [PDF]

Infect Dis Ther
Carrasquilla-Sotomayor M, Alvis-Zakzuk NJ, Coronell-Rodríguez W, Arias A, Moyano-Tamara L, Alvarado-Gonzalez JC, De la Hoz-Restrepo F, Alvis-Guzman N.   +7 more
europepmc   +1 more source

Acute Respiratory Infections in Children: A Narrative Perspective on Integrated Primary-Hospital Care in Italy. [PDF]

Children (Basel)
Indolfi C, Klain A, Dinardo G, Grella C, Cascone S, Miraglia Del Giudice M.   +5 more
europepmc   +1 more source

Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein. [PDF]

Antimicrob Agents Chemother
Liu S, Qiu X, Guo S, Wang L, Shen H, An M.   +5 more
europepmc   +1 more source

Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy. [PDF]

Pathogens
Gianotto NR, Ragusa N, Deut V, Mattivi C, Cherubini Scarafoni M, Dominici S, Mazzetti G, Sandei M, Lo Presti C, Manuela C, Calvo MM, Berger M.   +11 more
europepmc   +1 more source

Cell culture medium influences RSV G protein glycosylation and recognition by monoclonal antibodies. [PDF]

Virol J
Engling N, Knittler MC, Tagore R, Ludlow M, Osterhaus ADME, Rimmelzwaan GF, Meineke R.   +6 more
europepmc   +1 more source

Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. [PDF]

Infect Dis Ther
Alharbi AS, Abu-Shraie N, Al Abdulkarim H, Alharbi IH, Averin A, Law AW, Mendes D, Quinn E, Zayed M, Behiry A, Haridy H, Mousa M.   +11 more
europepmc   +1 more source